AMO ophthalmic viscosurgical device obtains CE Mark of Approval

Article

Abbott Medical Optics' Healon EndoCoat has received the European CE Mark of approval.

Abbott Medical Optics' Healon EndoCoat has received the European CE Mark of approval.

The viscous, low molecular ophthalmic viscosurgical device (OVD) is part of the Healon family and is currently available in Europe, Canada and New Zealand. The Food and Drug Administration (FDA) is presently reviewing the OVD for approval in the US.

Healon EndoCoat can be used as a surgical aid in cataract extraction, corneal transplantation and glaucoma filtration surgery and intraocular lens (IOL) implantation.

The properties of the approved OVD include the 25-gauge cannula delivery system with a guard. The OVD also lubricates and protects the eye during IOL implantation and can be combined with the original Healon OVD, Healon GVD OVD and Healon5 OVD.

Dr Donald Nixon, surgical director of TriMed Eye Center, Ontario, Canada, said: "The OVD plays an essential role in my cataract surgeries for overall endothelial cell preservation and patient safety."

Customers who presently order shipments of the Vitrax II OVD will be automatically updated to the Healon EndoCoat OVD.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.